The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

At Friends meeting, Pazdur, Woodcock lament FDA’s failure to protect the agency staff from political interference, warn of “lasting implications”

Bayer agrees to $7.25B settlement over lawsuits alleging Roundup weedkiller caused cancer

Super Bowl ad by Hims & Hers features GRAIL’s Galleri MCD test

FDA approves labeling changes to menopausal hormone therapy products

HHS withdraws 340B drug rebate pilot program

NIH’s Bhattacharya acknowledges absence of causal link between vaccines and autism

Clinical Roundup

ARPA-H opens first interventional clinical trials to outpace cancer in real time

Cancer cells’ ability to adapt could yield new treatment approaches, NYU-led study finds

NCCN guidelines detail fundamental differences between pediatric and adult cancers

Findings from Cincinnati Children’s study could make immune checkpoint inhibitors safer

Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer

Mount Sinai study strengthens evidence supporting lung-sparing surgery in mesothelioma

In The Clinic
Trials & Tribulations

Why infection and immunity matter for Florida’s cancer patients

FreeTrials & Tribulations
News Analysis
Health Equity

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account